177Lu-PSMA-VG01
PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
VitsGen Therapeutics Inc.Phase 1
—
Rating in progress
177Lu-PSMA-VG01 in PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active